PROZ
Basic information
Region (hg38): 13:113158648-113172386
Links
Phenotypes
GenCC
Source:
- protein Z deficiency (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Protein Z deficiency | AD | General | There is weak or mixed evidence that protein Z deficiency has an adverse health effect | General | 7495103; 10829076; 11289354; 11895801; 15638861; 14671240; 15626740; 16938126; 20076855 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PROZ gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 38 | 46 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 38 | 9 | 4 |
Variants in PROZ
This is a list of pathogenic ClinVar variants found in the PROZ region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-113158691-C-G | Protein Z deficiency | Uncertain significance (Nov 24, 2023) | ||
13-113160040-G-A | not specified | Uncertain significance (Mar 21, 2023) | ||
13-113160061-C-T | not specified | Uncertain significance (Mar 08, 2024) | ||
13-113160062-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
13-113160064-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
13-113160093-C-G | not specified | Uncertain significance (Jan 17, 2024) | ||
13-113160118-T-A | not specified | Uncertain significance (Apr 20, 2023) | ||
13-113160128-T-A | not specified | Uncertain significance (Sep 16, 2021) | ||
13-113160137-A-C | not specified | Uncertain significance (Oct 12, 2022) | ||
13-113160151-G-C | Protein Z deficiency | Affects (Apr 15, 2005) | ||
13-113160968-T-C | Benign (May 14, 2018) | |||
13-113163009-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
13-113163011-G-A | not specified | Uncertain significance (Mar 04, 2024) | ||
13-113163017-C-G | PROZ-related disorder | Likely benign (Jan 11, 2021) | ||
13-113163018-C-G | not specified | Uncertain significance (Aug 13, 2021) | ||
13-113163059-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
13-113163089-T-C | not specified | Uncertain significance (Dec 20, 2022) | ||
13-113163116-G-C | not specified | Uncertain significance (Feb 07, 2023) | ||
13-113164527-C-T | not specified | Uncertain significance (May 23, 2023) | ||
13-113164537-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
13-113164585-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
13-113164610-G-C | not specified | Uncertain significance (Jan 29, 2024) | ||
13-113164643-C-A | not specified | Uncertain significance (May 24, 2023) | ||
13-113165084-G-C | not specified | Uncertain significance (May 30, 2022) | ||
13-113165089-G-A | not specified | Uncertain significance (Dec 06, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PROZ | protein_coding | protein_coding | ENST00000342783 | 9 | 13727 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.18e-16 | 0.00149 | 125700 | 0 | 48 | 125748 | 0.000191 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0555 | 257 | 255 | 1.01 | 0.0000156 | 2727 |
Missense in Polyphen | 84 | 88.044 | 0.95407 | 1032 | ||
Synonymous | 0.380 | 101 | 106 | 0.953 | 0.00000742 | 826 |
Loss of Function | -0.900 | 22 | 17.9 | 1.23 | 9.65e-7 | 197 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000626 | 0.000626 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000246 | 0.000246 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Appears to assist hemostasis by binding thrombin and promoting its association with phospholipid vesicles. Inhibits activity of the coagulation protease factor Xa in the presence of SERPINA10, calcium and phospholipids.;
- Pathway
- Warfarin Pathway, Pharmacodynamics;Post-translational protein modification;Metabolism of proteins;Gamma-carboxylation of protein precursors;Removal of aminoterminal propeptides from gamma-carboxylated proteins;Gamma-carboxylation, transport, and amino-terminal cleavage of proteins;Gamma carboxylation, hypusine formation and arylsulfatase activation
(Consensus)
Recessive Scores
- pRec
- 0.257
Intolerance Scores
- loftool
- 0.261
- rvis_EVS
- -0.24
- rvis_percentile_EVS
- 36.17
Haploinsufficiency Scores
- pHI
- 0.109
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.397
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.310
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Proz
- Phenotype
- homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- proteolysis;endoplasmic reticulum to Golgi vesicle-mediated transport;blood coagulation
- Cellular component
- extracellular space;endoplasmic reticulum lumen;Golgi lumen;extracellular exosome
- Molecular function
- serine-type endopeptidase activity;calcium ion binding